Journals / Genel Tıp Dergisi / 2022 / Cilt: 32 - Sayı: 2

In Left-Sided Breast Cancer Radiotherapy Simulation; Prone or Supine position?

Sol Meme Kanseri Radyoterapisi SimülasyonundaPron pozisyon mu Supin pozisyon mu ?

Pages
31–36
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Considering that lower doses of normal structures may reduce side effects, prone position may be preferred in patients with left breast cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study was to compare radiation doses of target volumes and critical organs among prone and supine positions for left-sided breast cancer patients who were treated with breast-conserving surgery and adjuvant radiotherapy.
📊
Key Findings & Data:Results: The mean heart dose was lower in the prone position (mean heart doses 656cGy and 933cGy respectively p = 0.01).
💡
Conclusion & Impact:Conclusion: Considering that lower doses of normal structures may reduce side effects, prone position may be preferred in patients with left breast cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study was to compare radiation doses of target volumes and critical organs among prone and supine positions for left-sided breast cancer patients who were treated with breast-conserving surgery and adjuvant radiotherapy. Materials and Methods: The doses of critical organs and target volumes were evaluated by using dose-volume histograms on the new radiotherapy plans of twenty patients. Results: The mean heart dose was lower in the prone position (mean heart doses 656cGy and 933cGy respectively p = 0.01). Mean lung doses for prone and supine positions were 396 cGy and 1032 cGy (p =0.01); lung V5 13% and 33% (p =0.01); lung V10 8% and 25% (p =0.01); lung V20 5% and 17% (p =0.01). Conclusion: Considering that lower doses of normal structures may reduce side effects, prone position may be preferred in patients with left breast cancer.

Özet

Amaç : Bu çalışmanın amacı meme koruyucu cerrahi sonrası adjuvant radyoterapi uygulanmış sol meme kanseri tanısı olan hastalarda pron ve supin radyoterapi pozisyonlarının hedef hakim ve kritik organ dozları açısından karşılaştırılmasıdır. Gereç ve Yöntem : Hedef hakim ve kritik organ dozları doz-hacim histogramları kullanılarak değerlendirildi. Bulgular : Ortalama kalp dozu pron pozisyonda düşük bulundu ( pron ve supin pozisyon için sırasıyla 656 cGy ve 933 cGy ( p=0.01) bulundu.Pron ve supin pozisyonlar için ortalama akciğer dozları sırasıyla 396 cGy ve 1032 cGy (p=0.01); akciğer V5 %13 ve %33 (p=0.01); akciğer V10 %8 ve %25 (p=0.01); akciğer akciğer V20 %5 ve %17 (p=0.01) olarak tespit edildi. Sonuç: Kritik organlardaki düşük dozlar değerlendirildiğinde sol meme kanseri radyoterapisinde prone poziyonun tercih edilebileceği söylenebilir.

🔖

Cite This Article

ADAŞ, Y. G., KEKİLLİ, E. (2022). In Left-Sided Breast Cancer Radiotherapy Simulation; Prone or Supine position?. Genel Tıp Dergisi, Cilt: 32 - Sayı: 2, 31–36. https://ajindex.com/articles/524577

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin 2019
  2. 69(6):438-451. 2.Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002
  3. 347(16):1233-1241. 3.Early Breast Cancer Trialists' Collaborative G. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995
  4. 333(22):1444-1455. 4.Van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000
  5. 92(14):1143-1150. 5.Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002
  6. 347(16):1227-1232. 6.Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005
  7. 6(8):557-565. 7.Henson KE, McGale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer 2013
  8. 108(1):179-182. 8.Nielsen MH, Berg M, Pedersen AN, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol 2013
  9. 52(4):703-710. 9.Moiseenko V, Einck J, Murphy J, et al. Clinical evaluation of QUANTEC guidelines to predict the risk of cardiac mortality in breast cancer patients. Acta Oncol 2016
  10. 55(12):1506-1510. 10.Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010
  11. 76(3 Suppl):S70-76. 11.Jo IY, Kay CS, Kim JY, et al. Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases. J Radiat Res 2014
  12. 55(1):105-112. 12.Zhao H, He M, Cheng G, et al. A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT. Radiat Oncol 2015
  13. Hodapp N. [The ICRU Report 83: prescribing, record